1
|
Gürez C, Ergül N. Does Radioactive Iodine Treatment Damage the Lacrimal System? Clin Nucl Med 2024; 49:513-515. [PMID: 38451916 DOI: 10.1097/rlu.0000000000005147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/09/2024]
Abstract
PURPOSE In this prospective study, we aimed to make a quantitative assessment of the lacrimal glands before and after radioactive iodine (RAI) treatment in patients with hyperthyroidism and thyroid cancer. METHODS The study included 80 eyes of 40 patients. There were 25 patients in group 1 (hyperthyroid group) and 15 patients in group 2 (thyroid cancer group). Group 1 has received low dose ( 131 I) and group 2 high dose ( 131 I). Before, and at the first and sixth month after RAI treatment, all patients underwent ophthalmological examinations, Schirmer tests, TBUT tests, tear osmolarity (TO), and ocular surface examinations. RESULTS The age and sex characteristics of both groups were similar. Although no significant change was observed in tear film tests before and after treatment in group 1, a significant decrease in Schirmer and TBUT values and a significant increase in TO were observed in group 2 in the first month after treatment. These values returned to normal in the sixth month. Although no Schirmer test was observed lower than 10 mm in any patient before RAI treatment, the Schirmer test was measured 5 to 10 mm in 4 (10%) patients in group 2 in the first month after treatment. Again, in these patients, TBUT was below 10 seconds and TO was greater than 308 mOsm/L. CONCLUSIONS In this study, although no change was observed in tear function tests in patients receiving low doses of RAI, a decrease in tear secretion and an increase in TO were detected in patients receiving high doses in the early period.
Collapse
Affiliation(s)
- Ceren Gürez
- From the Ophthalmology Clinic, Beyoglu Eye Training and Research Hospital, Health of Sciences University
| | - Nurhan Ergül
- Nuclear Medicine Clinic, Istanbul Training and Research Hospital, Health of Sciences University, Istanbul, Turkey
| |
Collapse
|
2
|
Şingar E, Akbulut A, Koca G, Yazihan N, Atilgan Hİ, Yumuşak N, Demir A, Burcu A, Korkmaz M. The influencer effect of Dexmedetomidine on radioiodine relevant to lacrimal gland impairment. Int Ophthalmol 2024; 44:115. [PMID: 38411703 DOI: 10.1007/s10792-024-03052-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 02/16/2024] [Indexed: 02/28/2024]
Abstract
PURPOSE To assess the potential influencing effects of Dexmedetomidine on impaired lacrimal glands after high-dose radioiodine treatment (RAI). METHODS Thirty-six rats were arbitrarily separated into 3 groups: Sham, RAI, and Dexmedetomidine. Dexmedetomidine group was given Dexmedetomidine and RAI, the Sham group was given the same millimeters of saline, and the RAI group was given RAI only. All forms of lacrimal glands, including harderian glands (HG), extraorbital (EG), and intraorbital (IG) lacrimal glands, were evaluated for immunohistochemical, histopathologic assessments and also for tissue cytokines, oxidant and antioxidant levels. RESULTS Dexmedetomidine significantly ameliorated histopathologic changes such as periacinar fibrosis, acinar atrophy, lymphocytic infiltration, ductal proliferation, lipofuscin-like accumulation, and nucleus changes caused by RAI in all lacrimal gland forms (p < 0.05 for all of the parameters). However, periductal fibrosis was improved significantly only in EG (p = 0.049), and mast cell infiltration was improved significantly only in IG (p = 0.038) in Dexmedetomidine groups. There was a significant decrease in the elevated caspase-3 and TUNEL levels after RAI administration in the Dexmedetomidine group in all lacrimal gland forms (p < 0.05 for all parameters). Dexmedetomidine attenuated NF-kb, TNF-α, and IL-6 levels significantly diminished total oxidant status and raised total antioxidant status levels (p < 0.05 for all parameters). CONCLUSIONS The results of this study demonstrated that following RAI, Dexmedetomidine diminished inflammation, tissue cytokine levels, and apoptosis and ameliorated impaired histopathologic patterns of the lacrimal glands.
Collapse
Affiliation(s)
- Evin Şingar
- Department of Ophthalmology, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey.
| | - Aylin Akbulut
- Department of Nuclear Medicine, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey
| | - Gökhan Koca
- Department of Nuclear Medicine, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey
| | - Nuray Yazihan
- Department of Physiopathology, Ankara University, Ankara, Turkey
| | - Hasan İkbal Atilgan
- Department of Nuclear Medicine, Hatay Mustafa Kemal University, Hatay, Turkey
| | - Nihat Yumuşak
- Veterinary Faculty, Department of Pathology, Harran University, Sanliurfa, Turkey
| | - Ayten Demir
- Faculty of Nursing, Ankara University, Ankara, Turkey
| | - Ayse Burcu
- Department of Ophthalmology, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey
| | - Meliha Korkmaz
- Department of Nuclear Medicine, University of Health Sciences, Ankara Training and Research Hospital, Ankara, Turkey
| |
Collapse
|
3
|
Шеремета МС, Трухин АА, Ярцев ВД, Юдаков ДВ, Корчагина МО, Годжаева СА. [The lacrimal apparatus as an organ at risk during radionuclide therapy]. PROBLEMY ENDOKRINOLOGII 2024; 70:13-17. [PMID: 38433537 PMCID: PMC10926245 DOI: 10.14341/probl13163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Revised: 07/24/2023] [Accepted: 07/26/2023] [Indexed: 03/05/2024]
Abstract
Within the framework of the article, the authors analyzed the available information about the damage to the lacrimal apparatus during radionuclide therapy. In focus of article lesions of the lacrimal production system, the main and accessory lacrimal glands, as well as lacrimal drainage are considered. It was found that damage to the lacrimal apparatus is characteristic of 131I therapy for thyroid cancer, as well as for radioligand therapy using anti-PSMA antibodies labeled with 177Lu and 225Ac. 177Lu-PSMA and 225Ac-PSMA may damage the lacrimal gland with the formation of a clinically pronounced "dry eye syndrome". The pathogenesis of such lesions is associated with the accumulation of a radioisotope in the tissues of the lacrimal apparatus, while during therapy with 131I, accumulation is realized due to the expression of the sodium-iodine symporter in the nasolacrimal duct, and during therapy with 177Lu-PSMA and 225Ac-PSMA, the radiobiological effect is realized in connection with the expression PSMA by lacrimal tissue. An analysis of the available sources showed that to date there are no results of systematic studies on the problem, there is a lack of knowledge regarding the individual risks of developing these complications, methods for their prevention that have proven effectiveness have not been developed, and the treatment methods used, having relatively low efficiency, are not specialized. The authors concluded that the strengthening of interdisciplinary interaction, as well as the organization verification methodology and correct studies, can contribute to solving problems related to the study of the complications under consideration.
Collapse
Affiliation(s)
- М. С. Шеремета
- Национальный медицинский исследовательский центр эндокринологии
| | - А. А. Трухин
- Национальный медицинский исследовательский центр эндокринологии
| | - В. Д. Ярцев
- ФГБНУ «НИИ глазных болезней им. М.М. Краснова»
| | - Д. В. Юдаков
- Национальный медицинский исследовательский центр эндокринологии
| | - М. О. Корчагина
- Национальный медицинский исследовательский центр эндокринологии
| | - С. А. Годжаева
- ФГБНУ «НИИ глазных болезней им. М.М. Краснова»; Первый московский государственный медицинский университет имени И.М. Сеченова
| |
Collapse
|
4
|
Wu D, Plyku D, Kulkarni K, Garcia C, Burman KD, Wartofsky L, Van Nostrand D. The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging. Nucl Med Commun 2021; 42:292-299. [PMID: 33323865 DOI: 10.1097/mnm.0000000000001330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
METHODS 124I PET/CT in 31 DTC patients was performed at 2, 24, 48, 72, and 96 h after oral administration of 31.5 or 62.9 MBq (0.85 or 1.7 mCi) of 124I after either recombinant human thyroid-stimulating hormone injections or thyroid hormone withdrawal. All but two patients had a history of prior 131I therapy. Patterns of 124I uptake in the lacrimal glands and nasolacrimal sac/ducts (NLD) were assessed. RESULTS A total of 173 individual 124I PET/CT scans (forming 35 sets of scans) were reviewed for 31 patients. Lacrimal glands were visualized bilaterally in only 4 patients. The focal mild uptake (grade 2), best seen on the 2-h images, was crescent-shaped and located in the lateral upper quadrant of the orbit. In contrast, the NLDs were identified in all patients (bilateral in 29 of 31 patients) with high focal uptake (grade 4) peaking on the 2- and 24-h timepoints; however, the overall pattern of uptake was variable. Of the 29 patients with prior 131I therapy, three patients had a relatively fixed and unchanging pattern of uptake on at least one side of the NLDs. CONCLUSIONS In patients with DTC, 124I activity in the NLDs is more frequently visualized, more intense, more prolonged, and more variable than in the lacrimal glands. The lack of clearance may suggest possible obstruction or stasis of an NLD.
Collapse
Affiliation(s)
- Di Wu
- MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland
- Nuclear Medicine Research
| | - Donika Plyku
- MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland
- Nuclear Medicine Research
| | | | | | - Kenneth D Burman
- Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia, USA
| | - Leonard Wartofsky
- MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland
- Division of Endocrinology, MedStar Washington Hospital Center, Washington, District of Columbia, USA
| | - Douglas Van Nostrand
- MedStar Clinical Research Center, MedStar Health Research Institute, Hyattsville, Maryland
- Division of Nuclear Medicine
| |
Collapse
|
5
|
Koca G, Singar E, Akbulut A, Yazihan N, Yumuşak N, Demir A, Korkmaz M. The Effect of Resveratrol on Radioiodine Therapy-Associated Lacrimal Gland Damage. Curr Eye Res 2020; 46:398-407. [PMID: 32730712 DOI: 10.1080/02713683.2020.1803920] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
PURPOSE We have evaluated the potential radioprotective, antioxidant and anti-apoptotic effects of resveratrol (RSV) against high-dose radioactive iodine (RAI) therapy associated damage of the lacrimal glands by biochemical, histopathological and immunohistochemical methods. MATERIALS AND METHODS Thirty Wistar-albino rats were randomly divided into three groups; the control group received no treatment or medication, the RAI group received RAI but no medication and the RSV group received oral RAI and intraperitoneal RSV. RSV was started at day one, before RAI administration, and continued for 8 days. Bilateral intraorbital (IG), extraorbital (EG), and Harderian (HG) lacrimal glands were evaluated in all rats for histopathological, immunohistochemical, tissue cytokine and oxidant and antioxidant level assessment. RESULTS RSV group restored inflammation, fibrosis, vacuolization, change in nucleus characteristics, lipofuscin-like accumulation and cellular morphologic patterns were statistically significant in all lacrimal gland types, compared to the RAI group (p < .05 for all variables). Similarly, elevated Caspase-3 and TUNEL levels in the RAI group were significantly alleviated in the RSV group in all lacrimal gland types (p < .05 for all variables). RAI administration significantly elevated TNF-α, IL-6, NF-кb levels, and decreased IL-10 levels (p < .05 for all parameters) whereas TOS levels significantly increased and TAS levels were significantly decreased. However, RSV significantly diminished TNF-α, IL-6, IL-4, and NF-кb levels. Furthermore, RSV significantly decreased TOS and increased TAS levels (p < .05 for all variables). CONCLUSIONS We conclude that with its anti-cancer effect as well as its antioxidant effect RSV has protected the histopathological pattern of the lacrimal glands from the damage, decreased inflammation in histopathologic assessments, and decreased tissue cytokine levels, apoptosis and DNA fragmentation on the lacrimal glands after RAI.
Collapse
Affiliation(s)
- Gökhan Koca
- Department of Nuclear Medicine, Ankara Training and Application Hospital, University of Health Sciences , Ankara, Turkey
| | - Evin Singar
- Department of Ophthalmology, Ankara Training and Application Hospital, University of Health Sciences , Ankara, Turkey
| | - Aylin Akbulut
- Department of Nuclear Medicine, Ankara Training and Application Hospital, University of Health Sciences , Ankara, Turkey
| | - Nuray Yazihan
- Department of Pathophysiology, Ankara University School of Medicine , Ankara, Turkey
| | - Nihat Yumuşak
- Department of Pathology, Harran University Faculty of Veterinary Medicine , Sanliurfa, Turkey
| | - Ayten Demir
- Faculty of Health Sciences, Nursing Department, Ankara University , Ankara, Turkey
| | - Meliha Korkmaz
- Department of Nuclear Medicine, Ankara Training and Application Hospital, University of Health Sciences , Ankara, Turkey
| |
Collapse
|
6
|
Eksioglu U, Atilgan HI, Yakin M, Yazihan N, Altiparmak UE, Yumusak N, Korkmaz M, Demir A, Ornek F, Aribal Ayral P, Koca G. Antioxidant effects of vitamin D on lacrimal glands against high dose radioiodine-associated damage in an animal model. Cutan Ocul Toxicol 2018; 38:18-24. [PMID: 30003810 DOI: 10.1080/15569527.2018.1498507] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
PURPOSE To evaluate antioxidant effects of active vitamin D (calcitriol) against high-dose radioiodine (RAI) therapy-associated damage of lacrimal gland. MATERIALS AND METHODS Wistar albino rats were used and divided into three groups randomly (n = 12/group). The first group was appointed as the negative control group and received no RAI or medication. The second group was appointed as the positive control group that only received 3 mCi/kg (111 MBq/kg) RAI via gastric gavage and the last group was the treatment group that received 3 mCi/kg RAI via same method and calcitriol (200 ng/kg/day) via intraperitoneal administration. Seven days after RAI administration, bilateral intraorbital (IG), extraorbital (EG) and Harderian (HG) glands were removed for the evaluations of histopathologic, tissue cytokine, total oxidant status (TOS) and total antioxidant status (TAS). RESULTS RAI led to significant increase in tissue TOS, TNF-α, IL-6 levels and significant decrease in IL-10 and TAS levels (p < 0.05 for each). Addition of adjunctive calcitriol reversed all these parameters significantly (p < 0.05 for each).The following histopathologic parameters were seen more frequently in positive control group than the other groups: Abnormal lobular pattern, perivascular infiltration, periductal infiltration, lipofuscin-like accumulation, acinar atrophy, periductal and periacinar fibrosis in all lacrimal gland types (p < 0.05), acinar fibrosis in EG (p = 0.049), periductal fibrosis in EG and HG (p = 0.049 and 0.038, respectively), abnormal cell outlines in EG and HG (p = 0.020 and 0.011, respectively) and variation in cell size in the IG and the HG (p = 0.003 and 0.049 respectively). CONCLUSIONS RAI caused significant oxidative stress and inflammation in lacrimal glands. Vitamin D demonstrated potent anti-inflammatory, antioxidant and radio-protective effects on lacrimal glands in histopathologic, tissue cytokine and oxidant/antioxidant level evaluations.
Collapse
Affiliation(s)
- Umit Eksioglu
- a Department of Ophthalmology , Ankara Training and Research Hospital of University of Health Sciences , Ankara , Turkey
| | - Hasan Ikbal Atilgan
- b Department of Nuclear Medicine , Mustafa Kemal University, Faculty of Medicine , Turkey
| | - Mehmet Yakin
- a Department of Ophthalmology , Ankara Training and Research Hospital of University of Health Sciences , Ankara , Turkey
| | - Nuray Yazihan
- c Department of Pathophysiology , Ankara University, Faculty of Medicine , Ankara , Turkey
| | - Ugur Emrah Altiparmak
- d Department of Ophthalmology , Acibadem University Medical School, Acibadem Ankara Hospital , Ankara , Turkey
| | - Nihat Yumusak
- e Faculty of Veterinary Medicine , Harran University , Sanliurfa , Turkey
| | - Meliha Korkmaz
- f Department of Nuclear Medicine , Ankara Training and Research Hospital of University of Health Sciences , Ankara , Turkey
| | - Ayten Demir
- g Faculty of Health Sciences , Ankara University , Ankara , Turkey
| | - Firdevs Ornek
- a Department of Ophthalmology , Ankara Training and Research Hospital of University of Health Sciences , Ankara , Turkey
| | - Pelin Aribal Ayral
- c Department of Pathophysiology , Ankara University, Faculty of Medicine , Ankara , Turkey
| | - Gokhan Koca
- f Department of Nuclear Medicine , Ankara Training and Research Hospital of University of Health Sciences , Ankara , Turkey
| |
Collapse
|
7
|
Yakin M, Eksioglu U, Sadic M, Koca G, Ozkan-Uney G, Yumusak N, Husniye Telek H, Demir A, Yazihan N, Ornek F, Korkmaz M. Coenzyme Q10 for the Protection of Lacrimal Gland against High-Dose Radioiodine Therapy-Associated Oxidative Damage: Histopathologic and Tissue Cytokine Level Assessments in an Animal Model. Curr Eye Res 2017; 42:1590-1596. [PMID: 28937867 DOI: 10.1080/02713683.2017.1362006] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
Abstract
PURPOSE To evaluate protective effect of coenzyme Q10 (CoQ10) in lacrimal glands against high-dose radioactive iodine (RAI)-associated oxidative damage. MATERIALS AND METHODS Thirty Wistar albino rats were randomly divided into three groups. Group 1 was the control group. Group 2 received 3 mCi/kg RAI via gastric gavage but no medication. Group 3 received 3 mCi/kg RAI via gastric gavage and 30 mg/kg/day CoQ10 intraperitoneally. CoQ10 was started at day one just before RAI administration and continued for five days. Seven days after RAI therapy, the animals were anesthetized and decapitated. Intraorbital (IG), extraorbital (EG), and Harderian (HG) lacrimal glands were removed bilaterally for histopathological and tissue cytokine level assessments. RESULTS Abnormal lobular pattern, acinar fibrosis, lipofuscin-like accumulations, perivascular infiltration, cell size variation, abnormal cell outlines, irregular nucleus shapes in all lacrimal gland types (p < 0.05 for each), periductal fibrosis, periductal and periacinar fibrosis in EG (p = 0.01, 0.044, respectively) and in HG (p = 0.036, 0.044, respectively), periductal infiltration in HG (p = 0.039) and IG (p = 0.029), acinar atrophy in EG (p = 0.044), and cell shape variation in IG (p = 0.036) were observed more frequently in group 2 than in other groups. RAI caused significant increase in TNF-α, IL-6, nuclear factor kappa B, and total oxidant status, and decrease in IL-2, IL-10, and total antioxidant status levels (p < 0.05 for each). Addition of CoQ10 decreased all cytokine levels, increased nuclear factor kappa B levels more, and increased total antioxidant status levels significantly (p < 0.05 for each). CONCLUSIONS RAI administration causes prominent inflammatory response in lacrimal glands. Addition of CoQ10 ameliorates the oxidative damage and protects lacrimal glands both in histopathological and tissue cytokine level assessments. Protection of lacrimal glands against oxidative damage may become a new era of CoQ10 use in the future.
Collapse
Affiliation(s)
- Mehmet Yakin
- a Department of Ophthalmology , Ankara Training and Research Hospital , Ankara , Turkey
| | - Umit Eksioglu
- a Department of Ophthalmology , Ankara Training and Research Hospital , Ankara , Turkey
| | - Murat Sadic
- b Department of Nuclear Medicine , Ankara Training and Research Hospital , Ankara , Turkey
| | - Gokhan Koca
- b Department of Nuclear Medicine , Ankara Training and Research Hospital , Ankara , Turkey
| | - Guner Ozkan-Uney
- a Department of Ophthalmology , Ankara Training and Research Hospital , Ankara , Turkey
| | - Nihat Yumusak
- c Department of Pathology, Faculty of Veterinary Medicine , Harran University , Sanliurfa , Turkey
| | - Hande Husniye Telek
- a Department of Ophthalmology , Ankara Training and Research Hospital , Ankara , Turkey
| | - Ayten Demir
- d Faculty of Health Sciences , Ankara University , Ankara , Turkey
| | - Nuray Yazihan
- e Department of Pathophysiology , Ankara University Faculty of Medicine , Ankara , Turkey
| | - Firdevs Ornek
- a Department of Ophthalmology , Ankara Training and Research Hospital , Ankara , Turkey
| | - Meliha Korkmaz
- b Department of Nuclear Medicine , Ankara Training and Research Hospital , Ankara , Turkey
| |
Collapse
|
8
|
Kan S, Acar U, Kizilgul M, Beyazyildiz E, Cankaya A, Ozcelik O, Ozbek M. The effects of blood glucose regulation on tear function tests in diabetic patients. J Fr Ophtalmol 2017; 40:499-504. [DOI: 10.1016/j.jfo.2016.10.019] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Revised: 10/05/2016] [Accepted: 10/14/2016] [Indexed: 10/19/2022]
|
9
|
Kan S, Acar U, Kizilgul M, Beyazyildiz E, Cankaya AB, Apaydin M, Beysel S, Ozbek M. Tear Film and Ocular Surface Evaluation in Gestational Diabetes Mellitus. Semin Ophthalmol 2016; 33:402-406. [PMID: 28005448 DOI: 10.1080/08820538.2016.1250919] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
BACKGROUND Dry eye syndrome is one of the complaints of diabetic patients. The aim of the present study was to evaluate the tear functions in pregnant women with gestational diabetes mellitus (GDM) using tests: Schirmer, tear break-up time (TBUT), and tear film osmolarity (TFO) tests and the Ocular Surface Disease Index score (OSDI). METHODS Pregnant women with GDM (Group 1, n=46) and healthy pregnant women (Group 2, n=36) were enrolled. Initially, all participants were asked to answer the OSDI and then they underwent a detailed ophthalmic examination including Schirmer, TBUT, and TFO tests. The individuals with ocular or systemic disorders that might affect the tear function tests and who were using topical medications were excluded. RESULTS The results of Schirmer, TBUT, TFO tests and OSDI scores were 11.20±4.93 mm, 5.59±2.16 sec, 309.65±14.80 mOsm/L, and 9.59 ± 9.69 in Group 1, respectively, and 12.33±5.33 mm, 5.67±2.68 sec, 308.36±16.00 mOsm/L, and 10.62±8.66 in Group 2, respectively. There was no significant difference in any of the tear function tests and OSDI scores between the study groups (p>0.05). CONCLUSION GDM seems to have no negative effects on tear function tests. This may be due to a lack of duration of hyperglycemia long enough to affect the tear function tests of pregnant women.
Collapse
Affiliation(s)
- S Kan
- a Department of Endocrinology and Metabolism , Diskapi Training and Research Hospital , Ankara , Turkey
| | - U Acar
- b Department of Ophthalmology, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| | - M Kizilgul
- a Department of Endocrinology and Metabolism , Diskapi Training and Research Hospital , Ankara , Turkey.,c Schulze Diabetes Institute, University of Minnesota , Minneapolis , MN , USA
| | - E Beyazyildiz
- d Department of Ophthalmology , Samsun Teaching and Research Hospital , Samsun , Turkey
| | - A B Cankaya
- b Department of Ophthalmology, Faculty of Medicine , Hacettepe University , Ankara , Turkey
| | - M Apaydin
- a Department of Endocrinology and Metabolism , Diskapi Training and Research Hospital , Ankara , Turkey
| | - S Beysel
- a Department of Endocrinology and Metabolism , Diskapi Training and Research Hospital , Ankara , Turkey
| | - M Ozbek
- a Department of Endocrinology and Metabolism , Diskapi Training and Research Hospital , Ankara , Turkey
| |
Collapse
|
10
|
Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know. Ophthalmic Plast Reconstr Surg 2016; 32:243-8. [DOI: 10.1097/iop.0000000000000647] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
11
|
Ko KY, Kao CH, Lin CL, Huang WS, Yen RF. (131)I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study. Eur J Nucl Med Mol Imaging 2015; 42:1172-8. [PMID: 25900274 DOI: 10.1007/s00259-015-3055-0] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Accepted: 03/26/2015] [Indexed: 12/20/2022]
Abstract
OBJECTIVE The aim of this study was to determine the prevalence of salivary and lacrimal gland dysfunction and a second primary malignancy in patients from Taiwan with thyroid cancer after radioiodine therapy. METHODS This nationwide population-based cohort study was based on data obtained from the Taiwan National Health Insurance Database from 2000 to 2011. A total of 1,834 thyroid cancer patients treated with (131)I therapy and 1,834 controls (thyroid cancer without (131)I therapy) selected by 1:1 matching on a propensity score were enrolled. The cumulative (131)I dose in each patient was calculated. A Cox proportional hazards model was applied to estimate the effect of radiation from the (131)I therapy on the risk of salivary and lacrimal gland impairment as well as second primary malignancies in terms of hazard ratios (HRs) and 95% confidence intervals (CIs). RESULTS In patients treated with (131)I therapy and in controls, the incidence rates of salivary gland dysfunction were 6.76 and 1.01 per 10,000 person-years, respectively (HR 6.81, 95% CI 0.74 - 55.3), the incidence rates of keratoconjunctivitis sicca (KCS) were 13.6 and 16.3 per 10,000 person-years, respectively (HR 0.84, 95% CI 0.41 - 1.73), and the incidence rates of second primary malignancy were 76.7 and 62.4 per 10,000 person-years, respectively (HR 1.23, 95% CI 0.88 - 1.72). The risk of salivary secretion impairment significantly increased with increasing administered doses (HR 14.3, 95% CI 1.73 - 119.0). However, there was no increase in the incidence of KCS or secondary cancer in patients treated with higher doses. CONCLUSION (131)I therapy insignificantly increased the risk of salivary gland dysfunction and second primary malignancy. In patients with higher cumulative doses, an increase in the incidence of salivary gland dysfunction was observed. By contrast, we did not find an association between (131)I treatment and KCS development.
Collapse
Affiliation(s)
- Kuan-Yin Ko
- Department of Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan
| | | | | | | | | |
Collapse
|
12
|
Acar DE, Acar U, Yumusak N, Korkmaz M, Acar M, Atilgan HI, Yalniz-Akkaya Z, Koca G. Reducing the Histopathological Changes of Radioiodine to the Lacrimal Glands by a Popular Anti-Oxidant: Lycopene. Curr Eye Res 2014; 39:659-65. [DOI: 10.3109/02713683.2013.867354] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|